Subsequent studies in our team and other teams also find that BRD7 functions as a tumor suppressor in non-small cell lung cancer (NSCLC), osteosarcoma, endometrial carcinoma, and prostate cancer 27-30. This evidence concerns the gene BRD7 and endometrial carcinoma.